Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Transplant. 2013 Apr;13(4):1063-8. doi: 10.1111/ajt.12134. Epub 2013 Feb 7.

No impact of KIR-ligand mismatch on allograft outcome in HLA-compatible kidney transplantation.

Author information

1
Department of Transplantation Immunology, Institute of Immunology, University of Heidelberg, Heidelberg, Germany. hien.tran@med.uni-heidelberg.de

Abstract

Natural killer (NK) cell function can be modulated by the killer cell immunoglobulin-like receptors (KIR) which interact with human leukocyte antigen (HLA) class I molecules on target cells. KIR-ligand mismatching has recently been shown by van Bergen et al. (American Journal of Transplantation 2011; 11(9): 1959-1964) to be a significant risk factor for long-term graft loss in HLA-A, -B and -DR compatible kidney transplants. To verify this potentially important finding, we performed genotyping of 608 deceased-donor kidney graft recipients and their HLA-A, -B and -DR compatible donors for KIR and HLA, using samples and clinical data provided by the Collaborative Transplant Study. Graft survival of KIR-ligand-matched and -mismatched transplants was compared. We found no impact of KIR-ligand mismatching on 10-year graft survival in HLA-A, -B, -DR compatible kidney transplants. Further analysis did not reveal a significant effect of recipient activating/inhibitory KIR or KIR genotypes on graft survival. Our data do not support the concept that KIR-HLA matching might serve as a tool to improve long-term renal allograft survival.

PMID:
23398855
DOI:
10.1111/ajt.12134
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center